RAD vs RNV

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

RAD

RADIOPHARM FPO [RAD]

37LOW

RNV

RENERVE FPO [RNV]

37LOW

Score Breakdown

RAD RNV
Technical
38
42
Catalyst
51
52
Sentiment
50
50
Fundamental
76
46
Momentum
52
68
Risk Gate
27
42

Key Metrics

RAD Metric RNV
$42.6MMarket Cap$15.9M
4.7MAvg Volume (20d)146K
+0.1%Short InterestN/A
$0.04052-Week High$0.220
$0.01752-Week Low$0.090
+5.3%Daily Change+3.4%
$0.020Entry Price$0.092
-92.1%ROE-74.9%
-286.2%Profit MarginN/A

Active Signals

RAD Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Volume surging at 3.3x normal while price falls — heavy selling pressure
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (4 quarters) - dilution risk
●4C filed 2026-01-27
●Low P/S ratio (2.6x)
●Strong revenue growth (+154%)

RNV Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Above-average volume (1.5x) on a red day — sellers in control
●Drifting lower — down 7.1% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (4 quarters) - dilution risk
●Strong revenue growth (+60%)

Ask Scout AI to compare RAD and RNV in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
RAD Full Analysis → RNV Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).